Ian Blake

ORCID: 0009-0005-5720-4308
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 detection and testing
  • SARS-CoV-2 and COVID-19 Research
  • Long-Term Effects of COVID-19
  • Hepatitis B Virus Studies
  • Cervical Cancer and HPV Research
  • Diabetes and associated disorders
  • Animal Virus Infections Studies
  • Hepatitis C virus research
  • Pneumonia and Respiratory Infections
  • Respiratory viral infections research
  • Bacterial Infections and Vaccines
  • COVID-19 and healthcare impacts
  • Tracheal and airway disorders

Centers for Disease Control and Prevention
2024-2025

National Center for Emerging and Zoonotic Infectious Diseases
2024

Isolation is recommended during acute infection with SARS-CoV-2, the virus that causes COVID-19, but duration of infectiousness varies among individual persons. Rapid antigen test results have been correlated detection viable (1-3) and might inform isolation guidance, data are limited for recently emerged SARS-CoV-2 B.1.1.529 (Omicron) variant. On January 5, 2022, Yukon-Kuskokwim Health Corporation (YKHC) persons isolate 10 days after symptom onset (or, asymptomatic persons, a positive...

10.15585/mmwr.mm7108a3 article EN MMWR Morbidity and Mortality Weekly Report 2022-02-24

Abstract We used statewide surveillance data to describe the epidemiology of invasive Haemophilus influenzae type a (Hia) disease in Alaska during 2018–2022. Of 52 cases identified, 39 (75%) occurred among Native children aged <5 years who lived rural areas southwest or northern Alaska. Average annual incidence was 17.8 per 100,000 compared 0.3 persons ≥5 years. Among 43 years, 16 (37%) presented with meningitis and 6 (14%) died. Characterizing Hia can help direct prevention...

10.1093/infdis/jiaf132 article EN The Journal of Infectious Diseases 2025-03-11

Hepatitis C virus is a leading cause of chronic liver disease, hepatocellular carcinoma, and liver-related death targeted for global elimination as public health threat by 2030. Universal screening recommended all adults aged ≥18 years pregnant women during each pregnancy; periodic risk-based also recommended. Persons with current infection should be linked to antiviral treatment, which usually results in virologic cure within 8-12 weeks. To assess progress toward elimination, epidemiologic...

10.15585/mmwr.mm7410a1 article EN MMWR Morbidity and Mortality Weekly Report 2025-03-27

BackgroundEvidence suggests an increased risk of new-onset diabetes following COVID-19 infection. American Indian/Alaska Native (AI/AN) people were disparately impacted by the pandemic and historically have had higher incidence than other racial/ethnic groups in US. We measured association between infection incident AI/AN people.MethodsWe conducted a retrospective cohort study using de-identified patient data from Indian Health Service's (IHS) National Patient Information Reporting System....

10.1016/j.lana.2024.100727 article EN cc-by-nc-nd The Lancet Regional Health - Americas 2024-04-03
Coming Soon ...